{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:39Z","timestamp":1786724859365,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patterns"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.patter.2025.101453","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T14:52:32Z","timestamp":1770389552000},"page":"101453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosis"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-1865","authenticated-orcid":false,"given":"Maria","family":"Kuzikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelinn","family":"Kalman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagon","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Reinshagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Huchting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Tampere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"\u00d6stling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinton","family":"Seashore-Ludlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yojana","family":"Gadiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gribbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zaliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patter.2025.101453_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.colsurfb.2015.09.003","article-title":"Phospholipidosis effect of drugs by adsorption into lipid monolayers","volume":"136","author":"Ceccarelli","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.patter.2025.101453_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbrc.2008.09.121","article-title":"Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes","volume":"377","author":"Ikeda","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.patter.2025.101453_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/187231207779814292","article-title":"A role for lysosomal phospholipase A2 in drug induced phospholipidosis","volume":"1","author":"Abe","year":"2007","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.patter.2025.101453_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.abi4708","article-title":"Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2","volume":"373","author":"Tummino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.patter.2025.101453_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1293\/tox.21.9","article-title":"Drug-induced Phospholipidosis -Pathological Aspects and Its Prediction","volume":"21","author":"Nonoyama","year":"2008","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.patter.2025.101453_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28658","article-title":"Viruses and phospholipids: Friends and foes during infection","volume":"95","author":"Rattay","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.patter.2025.101453_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cells7110191","article-title":"The Hepatitis C Virus-Induced Membranous Web in Liver Tissue","volume":"7","author":"Blanchard","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.patter.2025.101453_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.patter.2025.101453_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1515\/hsz-2021-0383","article-title":"Corrigendum to: Emerging mechanisms of drug-induced phospholipidosis","volume":"403","author":"Breiden","year":"2021","journal-title":"Biol. Chem."},{"key":"10.1016\/j.patter.2025.101453_bib10","first-page":"517","article-title":"Drug-induced generalized phospholipidosis","volume":"22","author":"Shikata","year":"1972","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.patter.2025.101453_bib11","first-page":"613","article-title":"Drug-induced lipidosis in human cases and in animal experiments. Accumulation of an acidic glycerophospholipid","volume":"69","author":"Yamamoto","year":"1971","journal-title":"J. Biochem."},{"key":"10.1016\/j.patter.2025.101453_bib12","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.patter.2025.101453_bib13","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2174\/156802608786786589","article-title":"Weka machine learning for predicting the phospholipidosis inducing potential","volume":"8","author":"Ivanciuc","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.patter.2025.101453_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/15376510701857262","article-title":"Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models","volume":"18","author":"Kruhlak","year":"2008","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.patter.2025.101453_bib15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1021\/mp100103e","article-title":"Predicting phospholipidosis using machine learning","volume":"7","author":"Lowe","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.patter.2025.101453_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/minf.201380141","article-title":"Notification: Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds","volume":"32","author":"Orogo","year":"2013","journal-title":"Mol. Inform."},{"key":"10.1016\/j.patter.2025.101453_bib17","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acs.molpharmaceut.7b00388","article-title":"Predicting the Risk of Phospholipidosis with in Silico Models and an Image-Based in Vitro Screen","volume":"14","author":"Fusani","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.patter.2025.101453_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.comtox.2022.100226","article-title":"Development of an in silico consensus model for the prediction of the phospholipigenic potential of small molecules","volume":"22","author":"Schieferdecker","year":"2022","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.patter.2025.101453_bib19","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.chembiol.2023.09.003","article-title":"A machine learning and live-cell imaging tool kit uncovers small molecules induced phospholipidosis","volume":"30","author":"Hu","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.patter.2025.101453_bib20","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acs.molpharmaceut.3c00964","article-title":"AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis","volume":"21","author":"Lomuscio","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.patter.2025.101453_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153165","article-title":"Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties","volume":"7","author":"Bennett","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.patter.2025.101453_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1758-2946-4-2","article-title":"Predicting the mechanism of phospholipidosis","volume":"4","author":"Lowe","year":"2012","journal-title":"J. Cheminform."},{"key":"10.1016\/j.patter.2025.101453_bib23","article-title":"Colloidal aggregation confounds cell-based Covid-19 antiviral screens","author":"Glenn","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.patter.2025.101453_bib24","article-title":"Sphingolipid biosynthesis inhibition as s host Sstrategy against diverse pathogens.","author":"Kumar","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.patter.2025.101453_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-022-01532-x","article-title":"Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort","volume":"9","author":"Zaliani","year":"2022","journal-title":"Sci. Data"},{"key":"10.1016\/j.patter.2025.101453_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-021-00848-4","article-title":"A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection","volume":"8","author":"Ellinger","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.patter.2025.101453_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cpt.3701","article-title":"FDA Adverse Event Reporting System (FAERS) Essentials: A Guide to Understanding, Applying, and Interpreting Adverse Event Data Reported to FAERS","volume":"118","author":"Potter","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.patter.2025.101453_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaf081","article-title":"From library to landscape: integrative annotation workflows for compound libraries in drug repurposing","author":"Reinshagen","year":"2025","journal-title":"Database"},{"key":"10.1016\/j.patter.2025.101453_bib29","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/acsptsci.0c00216","article-title":"Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen","volume":"4","author":"Kuzikov","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.patter.2025.101453_bib30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.patter.2025.101453_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.patter.2025.101453_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/ci050457y","article-title":"ErG: 2D pharmacophore descriptions for scaffold hopping","volume":"46","author":"Stiefl","year":"2006","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.patter.2025.101453_bib33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: Synthetic Minority Over-sampling Technique","volume":"16","author":"Chawla","year":"2002","journal-title":"J. Artif. Intell. Res."},{"key":"10.1016\/j.patter.2025.101453_bib34","author":"Kuzikov"},{"key":"10.1016\/j.patter.2025.101453_bib35","author":"Kuzikov"},{"key":"10.1016\/j.patter.2025.101453_bib36","author":"Kuzikov"}],"container-title":["Patterns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666389925003010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666389925003010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:29:15Z","timestamp":1786721355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666389925003010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666389925003010"],"URL":"https:\/\/doi.org\/10.1016\/j.patter.2025.101453","relation":{},"ISSN":["2666-3899"],"issn-type":[{"value":"2666-3899","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experimental and machine learning-based exploration of repurposed drugs reveals chemical features underlying phospholipidosis","name":"articletitle","label":"Article Title"},{"value":"Patterns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.patter.2025.101453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101453"}}